Australia's most trusted
source of pharma news
Saturday, 20 April 2024
Posted 21 January 2022 AM
Medicines Australia has inducted its first new member for 2022 - the third company to join the industry body in as many months.
Alexion, which was bought by AstraZeneca in 2021 to build its rare diseases portfolio, has joined as a Class Two member.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.